Haroun Gajraj/LinkedIn
Nov 15, 2025, 15:42
Haroun Gajraj Thanks Enric Roche for Demonstrating the Piston Effect
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, reposted from Enric Roche, on LinkedIn:
“Thank you, Enric Roche, MD, PhD, for a very nice demonstration of the piston effect in foam sclerotherapy.”
Quoting Enric Roche’s post:
“This is what we call the piston effect in foam sclerotherapy. The foam uniformly displaces the blood, maintaining its structure and promoting contact between the sclerosant and the endothelium. To optimise this effect in all concentrations and drugs is always an advantage to get better outcomes. This behaviour occurs with dry foams due to their greater stability.
This is a 0.2% Polidocanol foam.”

Stay informed with Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics